250 related articles for article (PubMed ID: 26940775)
1. A genetic view of laryngeal cancer heterogeneity.
de Miguel-Luken MJ; Chaves-Conde M; Carnero A
Cell Cycle; 2016 May; 15(9):1202-12. PubMed ID: 26940775
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival.
de Miguel-Luken MJ; Chaves-Conde M; Quintana B; Menoyo A; Tirado I; de Miguel-Luken V; Pachón J; Chinchón D; Suarez V; Carnero A
Oncotarget; 2016 May; 7(22):31723-37. PubMed ID: 27166270
[TBL] [Abstract][Full Text] [Related]
3. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008.
Cuny F; Meunier A; Heutte N; Rame JP; De Raucourt D; Babin E; Blanchard D
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):129-34. PubMed ID: 25838235
[TBL] [Abstract][Full Text] [Related]
4. The molecular biology of laryngeal cancer.
Ha PK; Califano JA
Otolaryngol Clin North Am; 2002 Oct; 35(5):993-1012. PubMed ID: 12587244
[TBL] [Abstract][Full Text] [Related]
5. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding?
Nakayama M; Okamoto M; Hayakawa K; Miyamoto S; Ishiyama H; Komori S; Okamoto T; Seino Y; Kano K; Soda I; Sekiguchi A; Kawakami S
Jpn J Clin Oncol; 2014 Jan; 44(1):57-64. PubMed ID: 24174633
[TBL] [Abstract][Full Text] [Related]
8. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
[TBL] [Abstract][Full Text] [Related]
9. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Forastiere AA; Ismaila N; Lewin JS; Nathan CA; Adelstein DJ; Eisbruch A; Fass G; Fisher SG; Laurie SA; Le QT; O'Malley B; Mendenhall WM; Patel S; Pfister DG; Provenzano AF; Weber R; Weinstein GS; Wolf GT
J Clin Oncol; 2018 Apr; 36(11):1143-1169. PubMed ID: 29172863
[TBL] [Abstract][Full Text] [Related]
10. State of the art in the treatment of laryngeal cancer.
Jenckel F; Knecht R
Anticancer Res; 2013 Nov; 33(11):4701-10. PubMed ID: 24222104
[TBL] [Abstract][Full Text] [Related]
11. Modified TALK Score for Japanese Patients with Laryngeal and Hypopharyngeal Cancers to Predict the Possibility of Laryngeal Preservation by Concurrent Chemoradiotherapy.
Otsuki N; Matsui M; Takahashi M; Sasaki R; Kiyota N; Usami M; Nibu KI
Kobe J Med Sci; 2018 Apr; 63(4):E113-E122. PubMed ID: 29955023
[TBL] [Abstract][Full Text] [Related]
12. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
13. Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.
Tangsriwong K; Jitreetat T
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2051-2057. PubMed ID: 31350965
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
15. Functional organ preservation for laryngeal cancer: past, present and future.
Nakayama M; Laccourreye O; Holsinger FC; Okamoto M; Hayakawa K
Jpn J Clin Oncol; 2012 Mar; 42(3):155-60. PubMed ID: 22223858
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary Care of Laryngeal Cancer.
Salvador-Coloma C; Cohen E
J Oncol Pract; 2016 Aug; 12(8):717-24. PubMed ID: 27511718
[TBL] [Abstract][Full Text] [Related]
17. Quality of Life After Conservation Surgery for Laryngeal Cancer.
Sadoughi B
Otolaryngol Clin North Am; 2015 Aug; 48(4):655-65. PubMed ID: 26092764
[TBL] [Abstract][Full Text] [Related]
18. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
19. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
